Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study
Clinical trial NCT01140542 · COMPLETED
Trial details
- NCT number
- NCT01140542
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-11-01
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.